Announcing the Green Button Oncology Consult
Introducing a Self-Service ‘Digital Consult’ for Oncology
Earlier this month, Atropos Health announced a major partnership with the American Society of Clinical Oncology (ASCO). Atropos is harnessing real-world data from the CancerLinQ platform – a popular service used by oncologists at ~100 cancer centers and practices to help them to deliver the best possible care to cancer patients. The partnership's goal is to deliver intelligent, actionable insights directly to the bedside, immediately impacting care delivery.
Automating the Prognostogram
When we say immediately impacting care delivery, we mean it. Through the Prognostogram Informatics Consult, Atropos Health can answer complex medical questions in under 24-hours so providers can make decisions based on real-world evidence from millions of patient records.
This summer, we are making this “digital consult” immediate for various cancer-related care decisions. This will be available to both oncologists and primary care physicians, helping navigate the complexity of patient care decisions as they treat both the cancer itself and other ailments that a patient may be suffering from.
This new application will impact all stages of care delivery, from initial treatment plans to remission and end of life care, with questions answered automatically after providers input certain patient attributes such as demographics and cancer diagnosis.
Click here to sign up to beta test our self-service product this summer!
Better Outcomes for Vulnerable Patients
The goal here is simple: We want to improve the overall health of a patient. The more we can bring real-world evidence and put it into the hands of clinicians, the better off patients will be. A self-service model makes this possible.
Atropos and CancerLinQ have begun recruiting practices to participate in a pilot program planned to start later this year. This gives us a chance to ensure what we offer is fine-tuned in a real care setting, where we can begin to see immediate results.
Atropos Health’s success is proven by peer-reviewed research, which you can find here. To learn more about CancerLinQ or to participate in the pilot launch of the oncology digital consult, click here or visit us at the CancerLinQ booth at the ASCO Annual Meeting (booth #5005).
Learn more by visiting us at the ASCO CancerLinQ booth (#5005) at the ASCO Annual Meeting in Chicago June 3-7 or schedule some time to meet with us at the annual meeting here
